Particular  ||| S:0 E:11 ||| JJ
aspects  ||| S:11 E:19 ||| NNS
in  ||| S:19 E:22 ||| IN
endoscopic  ||| S:22 E:33 ||| JJ
surgery  ||| S:33 E:41 ||| NN
for  ||| S:41 E:45 ||| IN
juvenile  ||| S:45 E:54 ||| JJ
nasopharyngeal  ||| S:54 E:69 ||| JJ
angiofibromas ||| S:69 E:82 ||| NN
.  ||| S:82 E:84 ||| .
Case  ||| S:84 E:89 ||| NN
reports  ||| S:89 E:97 ||| NNS
and  ||| S:97 E:101 ||| CC
review  ||| S:101 E:108 ||| NN
of  ||| S:108 E:111 ||| IN
literature  ||| S:111 E:122 ||| FW
Juvenile  ||| S:122 E:131 ||| FW
nasopharyngeal  ||| S:131 E:146 ||| FW
angiofibromas  ||| S:146 E:160 ||| FW
( ||| S:160 E:161 ||| -LRB-
JNA ||| S:161 E:164 ||| NNP
)  ||| S:164 E:166 ||| -RRB-
are  ||| S:166 E:170 ||| VBP
rare ||| S:170 E:174 ||| JJ
,  ||| S:174 E:176 ||| ,
benign ||| S:176 E:182 ||| JJ
,  ||| S:182 E:184 ||| ,
highly  ||| S:184 E:191 ||| RB
vascular  ||| S:191 E:200 ||| JJ
tumors  ||| S:200 E:207 ||| NNS
which  ||| S:207 E:213 ||| WDT
appear  ||| S:213 E:220 ||| VBP
in  ||| S:220 E:223 ||| IN
proximity  ||| S:223 E:233 ||| VBG
to  ||| S:233 E:236 ||| TO
the  ||| S:236 E:240 ||| DT
sphenopalatine  ||| S:240 E:255 ||| JJ
foramen ||| S:255 E:262 ||| NN
.  ||| S:262 E:264 ||| .
The  ||| S:264 E:268 ||| DT
tumor  ||| S:268 E:274 ||| NN
arises  ||| S:274 E:281 ||| VBZ
most  ||| S:281 E:286 ||| RBS
commonly  ||| S:286 E:295 ||| RB
in  ||| S:295 E:298 ||| IN
adolescent  ||| S:298 E:309 ||| JJ
males  ||| S:309 E:315 ||| NNS
suggesting  ||| S:315 E:326 ||| VBG
that  ||| S:326 E:331 ||| IN
in  ||| S:331 E:334 ||| IN
could  ||| S:334 E:340 ||| MD
be  ||| S:340 E:343 ||| VB
hormonally  ||| S:343 E:354 ||| JJ
responsive ||| S:354 E:364 ||| NN
.  ||| S:364 E:366 ||| .
Although  ||| S:366 E:375 ||| IN
it  ||| S:375 E:378 ||| PRP
is  ||| S:378 E:381 ||| VBZ
histologically  ||| S:381 E:396 ||| JJ
benign ||| S:396 E:402 ||| NN
,  ||| S:402 E:404 ||| ,
it  ||| S:404 E:407 ||| PRP
has  ||| S:407 E:411 ||| VBZ
a  ||| S:411 E:413 ||| DT
high  ||| S:413 E:418 ||| JJ
destructive  ||| S:418 E:430 ||| JJ
potential  ||| S:430 E:440 ||| NN
and  ||| S:440 E:444 ||| CC
a  ||| S:444 E:446 ||| DT
high  ||| S:446 E:451 ||| JJ
grade  ||| S:451 E:457 ||| NN
of  ||| S:457 E:460 ||| IN
recurrence ||| S:460 E:470 ||| NN
.  ||| S:470 E:472 ||| .
It  ||| S:472 E:475 ||| PRP
is  ||| S:475 E:478 ||| VBZ
a  ||| S:478 E:480 ||| DT
fibrous  ||| S:480 E:488 ||| JJ
vascular  ||| S:488 E:497 ||| JJ
tumor  ||| S:497 E:503 ||| NN
with  ||| S:503 E:508 ||| IN
vascular  ||| S:508 E:517 ||| JJ
sources  ||| S:517 E:525 ||| NNS
from  ||| S:525 E:530 ||| IN
branches  ||| S:530 E:539 ||| NNS
of  ||| S:539 E:542 ||| IN
the  ||| S:542 E:546 ||| DT
external  ||| S:546 E:555 ||| JJ
or  ||| S:555 E:558 ||| CC
internal  ||| S:558 E:567 ||| JJ
carotid  ||| S:567 E:575 ||| JJ
arteries ||| S:575 E:583 ||| NNS
.  ||| S:583 E:585 ||| .
Modern  ||| S:585 E:592 ||| JJ
treatment  ||| S:592 E:602 ||| NN
of  ||| S:602 E:605 ||| IN
JNA  ||| S:605 E:609 ||| NNP
includes  ||| S:609 E:618 ||| VBZ
surgery  ||| S:618 E:626 ||| NN
and  ||| S:626 E:630 ||| CC
also  ||| S:630 E:635 ||| RB
radiotherapy ||| S:635 E:647 ||| JJ
,  ||| S:647 E:649 ||| ,
chemotherapy  ||| S:649 E:662 ||| NN
and  ||| S:662 E:666 ||| CC
hormone  ||| S:666 E:674 ||| JJ
therapy ||| S:674 E:681 ||| NN
.  ||| S:681 E:683 ||| .
This  ||| S:683 E:688 ||| DT
paper  ||| S:688 E:694 ||| NN
presents  ||| S:694 E:703 ||| VBZ
two  ||| S:703 E:707 ||| CD
cases  ||| S:707 E:713 ||| NNS
from  ||| S:713 E:718 ||| IN
the  ||| S:718 E:722 ||| DT
eight  ||| S:722 E:728 ||| CD
of  ||| S:728 E:731 ||| IN
our  ||| S:731 E:735 ||| PRP$
clinic ||| S:735 E:741 ||| NN
's  ||| S:741 E:744 ||| POS
experience ||| S:744 E:754 ||| NN
,  ||| S:754 E:756 ||| ,
with  ||| S:756 E:761 ||| IN
morphological  ||| S:761 E:775 ||| JJ
features  ||| S:775 E:784 ||| NNS
which  ||| S:784 E:790 ||| WDT
made  ||| S:790 E:795 ||| VBD
their  ||| S:795 E:801 ||| PRP$
treatment  ||| S:801 E:811 ||| NN
challenging ||| S:811 E:822 ||| VBG
.  ||| S:822 E:824 ||| .
